Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region

Background Human leukocyte antigen (HLA)-DR2 carriership is associated with an increased risk for MS. Genome searches using microsatellite markers have consistently shown that additional genetic factors contribute to susceptibility for MS. ObjectiveTo identify loci within the HLA region that predispose to relapse-onset MS independently of HLA-DR2. MethodA case–control study involving 159 patients with definite relapse-onset MS and 273 control subjects was conducted. Six highly polymorphic microsatellite markers encoded within the HLA-C to DR region, that is, D6S1014, D6S273, TNFa, MIB, C1_2_5, and C1_3_2, three single-nucleotide tumor necrosis factor (TNF) promoter gene polymorphisms at positions −238, −308, and −376, and HLA-DR2 carriership were typed. Results These data confirmed the well-known association between the HLA-DR2 haplotype and relapse-onset MS, yielding an odds ratio (OR) of 3.6 (95% CI: 2.4 to 5.4;p < 0.0001). Multivariate analyses revealed that C1_3_2*354 was also associated with an increased risk for developing relapse-onset MS independently of HLA-DR2 (OR: 2.0; 95% CI: 1.2 to 3.1;p = 0.004). This allele is encoded within an ancestral haplotype that is highly linked to HLA-DR3. The joint effect of this ancestral haplotype and HLA-DR2 resulted in an OR of 8.7 (95% CI: 2.7 to 29;p < 0.0001) to develop relapse-onset MS. In addition, a protective risk factor was found: carriers of TNFa*107 had a 0.5-fold lower risk to develop relapse-onset MS (95% CI: 0.3 to 0.9;p = 0.026). ConclusionWithin the HLA region, other loci besides HLA-DR2 haplotype modulate susceptibility for relapse-onset MS.

[1]  T. Huizinga,et al.  Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production , 2002, Genes and Immunity.

[2]  D. Clayton,et al.  Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia , 2001, Genetic epidemiology.

[3]  F. Breedveld,et al.  The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. , 2001, Human immunology.

[4]  C. Polman,et al.  Innate production of interleukin‐10 and tumor necrosis factor affects the risk of multiple sclerosis , 2000, Annals of neurology.

[5]  C. Kumana,et al.  Association studies of genetic polymorphisms and complex disease , 2000, The Lancet.

[6]  G. Lucotte,et al.  TNF-α polymorphisms in multiple sclerosis: no association with −238 and −308 promoter alleles, but the microsatellite allele all is associated with the disease in French patients , 2000, Multiple sclerosis.

[7]  A. Geluk,et al.  Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. , 2000, Human immunology.

[8]  J. Hillert,et al.  Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. , 2000 .

[9]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[10]  E. G. de la Concha,et al.  Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis , 1999, Neurology.

[11]  D. Middleton,et al.  A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis , 1999, Journal of the Neurological Sciences.

[12]  A. Cambon-Thomsen,et al.  Microsatellites in the HLA region: 1998 update. , 1998, Tissue antigens.

[13]  J. Haines,et al.  Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. , 1998, Human molecular genetics.

[14]  K. Selmaj,et al.  Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha , 1998, Journal of Neuroimmunology.

[15]  G. Wong,et al.  TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination , 1998, Nature Medicine.

[16]  F. Muntoni,et al.  Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. , 1997, American journal of human genetics.

[17]  B. Weinshenker,et al.  A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis , 1997, Neurology.

[18]  Moses Rodriguez,et al.  Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor‐α in the central nervous system , 1997, European journal of immunology.

[19]  H. Przuntek,et al.  Genetic predisposition to multiple sclerosis as revealed by immunoprinting , 1997, Annals of neurology.

[20]  C. Polman,et al.  TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients , 1997, Journal of Neuroimmunology.

[21]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[22]  F. Weber,et al.  Gene polymorphism at position −308 of the tumor-necrosis -factor-α (TNF-α) in Multiple Sclerosis and it's influence on the regulation of TNF-α production , 1996, Neuroscience Letters.

[23]  P. Goodfellow,et al.  A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 , 1996, Nature Genetics.

[24]  J. Haines,et al.  A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex , 1996, Nature Genetics.

[25]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[26]  M. Carrington,et al.  Recombination rates across the HLA complex: use of microsatellites as a rapid screen for recombinant chromosomes. , 1995, Human molecular genetics.

[27]  A. Cambon-Thomsen,et al.  Tumor necrosis factor polymorphisms in multiple sclerosis: No additional association independent of HLA , 1994, Journal of Neuroimmunology.

[28]  A. Cambon-Thomsen,et al.  Tumor necrosis factor microsatellites in four European populations. , 1993, Human immunology.

[29]  A. Cambon-Thomsen,et al.  Microsatellite, restriction fragment-length polymorphism, and sequence-specific oligonucleotide typing of the tumor necrosis factor region. Comparisons of the 4AOHW cell panel. , 1993, Human immunology.

[30]  J. Hillert,et al.  Multiple sclerosis is associated with genes within or close to the HLA‐DR‐DQ subregion on a normal DR15, DQ6, Dw2 haplotype , 1993, Neurology.

[31]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[32]  W. Klitz,et al.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. , 1992, Journal of immunology.

[33]  J. Hillert,et al.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.

[34]  T. Olsson,et al.  Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[36]  G. Stewart,et al.  HLA family studies and multiple sclerosis: A common gene, dominantly expressed. , 1981, Human immunology.